Alberta Children's Hospital is the largest public hospital for sick children in the prairie provinces, and is located in Calgary, Alberta, Canada. It is operated by Alberta Health Services – Calgary Health Region.

During the past decade, Alberta Children's Hospital conducted 148 clinical trials. In the 10-year time frame, 148 clinical trials started and 87 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 49 clinical trials were completed. i.e. 89.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alberta Children's Hospital" #1 sponsor was "Children's Oncology Group" with 96 trials, followed by "University of Calgary" with 45 trials sponsored, "National Cancer Institute (NCI)" with 21 trials sponsored, "The Hospital for Sick Children" with 20 trials sponsored and "Hoffmann-La Roche" with 20 trials sponsored. Other sponsors include 147 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alberta Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 98 trials as a collaborator, "Alberta Children's Hospital" with 21 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 21 trials as a collaborator, "The Hospital for Sick Children" with 14 trials as a collaborator and "Children's Hospital of Eastern Ontario" with 9 trials as a collaborator. Other collaborators include 386 different institutions and companies that were collaborators in the rest 229 trials.

According to Clinical.Site data, the most researched conditions in "Alberta Children's Hospital" are "Duchenne Muscular Dystrophy" (24 trials), "Leukemia" (23 trials), "Neuroblastoma" (13 trials), "Lymphoma" (11 trials) and "Sarcoma" (11 trials). Many other conditions were trialed in "Alberta Children's Hospital" in a lesser frequency.

Most popular intervention types in "Alberta Children's Hospital" are "Drug" (204 trials), "Other" (89 trials), "Biological" (68 trials), "Procedure" (52 trials) and "Radiation" (46 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Cyclophosphamide" (34 trials), "Placebo" (28 trials), "cyclophosphamide" (28 trials) and "Vincristine Sulfate" (26 trials). Other intervention names were less common.

The vast majority of trials in "Alberta Children's Hospital" are 307 trials for "All" genders, 33 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 118 active trials in "Alberta Children's Hospital". 2 are not yet recruiting, 69 are recruiting, 41 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 177 completed trials in Alberta Children's Hospital, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Alberta Children's Hospital, 31 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 50 trials that are defined as “Not Applicable".